Aesthetics Advisor

FEBRUARY 23, 2025

Alexs eczema, also known as atopic dermatitis, began in infancy with small, itchy patches on his wrists and handsa condition Kate, a seasoned nurse, was familiar with. He was later prescribed UVB narrowband phototherapy, a treatment using UVB light to reduce skin inflammation. After six months, his eczema was completely gone.

Eczema 36

Eczema Dermatitis Medical Clinic 36

First Derm

APRIL 5, 2024

Factors affecting adherence include socioeconomic status, treatment complexity, and the specific skin condition being treated. Strategies to improve adherence range from using eHealth tools and educational resources to simplifying treatment regimens.

Dermatology 45

Dermatology Treatments Education Medical 45

The Dermatology Digest

MARCH 13, 2024

Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences in Washington, DC, shares his excitement about chronic spontaneous urticaria (CSU) treatments coming down the pike including remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase inhibitor.

Treatments 36

Treatments Dermatitis Dermatology Eczema 36

First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Who’s at Risk : Affects both genders and all ages, but more common in infants and children with atopic dermatitis.

Eczema 52

Eczema Dermatitis Clinic Medical 52

First Derm

JUNE 14, 2022

These rashes can also be quite severe, and they may require medical treatment. There is no cure for eczema, but there are treatments that can help to relieve symptoms and prevent flare-ups. Common treatments include moisturizers, corticosteroid creams, and antihistamines. Contact dermatitis can be either acute or chronic.

Eczema 52

Eczema Dermatitis Irritation Medical 52

The Dermatology Digest

MARCH 13, 2024

Silverberg, MD, Chief of Pediatric Dermatology for the Mount Sinai Health System in New York, reviews the rationale for treating Molluscum Contagiosum and shares updates on available treatments including disruptive techniques and the newly approved Zelsuvmi (berdazimer topical gel, 10.3% (Zelsuvmi, Ligand) cantharidin (Ycanth, Verrica).

Treatments 28

Treatments Dermatitis Dermatology Eczema 28

The Dermatology Digest

JANUARY 14, 2024

The overwhelming majority of people with atopic dermatitis (AD) treated with investigational roflumilast cream 0.15% (Zoryve, Arcutis) showed a measurable improvement in Eczema Area and Severity Index (EASI) in 4 weeks, according to new pooled analyses from two Phase 3 studies.

Dermatitis 36

Dermatitis Safety Dermatology Hospital 36

The Dermatology Digest

MARCH 11, 2024

Sanofi’s investigational OX40-ligand blocker amlitelimab produces sustained improvement in the signs and symptoms of atopic dermatitis (AD) in adults who previously responded and continued treatment and sustained off-drug improvements in those who stopped treatment. of patients withdrawn from treatment, the study showed.

Sustainability 36

Sustainability Dermatitis Safety Hospital 36

The Dermatology Digest

JANUARY 30, 2024

The 2023 PeDRA Research Grant recipients are: Joyce Teng, MD, PhD of Stanford University, will conduct a project titled “ A Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of a Hypertonic Gel in the Treatment of Pediatric Cutaneous Pyogenic Granuloma.

Partnerships 36

Partnerships Eczema Hospital Dermatology 36

The Dermatology Digest

JANUARY 7, 2024

Led by Louisville, KY dermatologist Joe Fowler, MD, and George Martin, MD, a dermatologist in Kihei, HI, and Maui Derm Program Chairman, the four-day meeting will feature treatment updates on psoriasis, atopic dermatitis, acne/rosacea, pigmentation disorders, blistering diseases, pediatric dermatology and more. Rosen tells TDD.

Dermatitis 36

Dermatitis Dermatology Rosacea Hospital 36

The Dermatology Digest

MARCH 13, 2024

Genodermatoses can masquerade as atopic dermatitis (AD). Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Think Twice: Is It Really AD?

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 11, 2024

Joshua Zeichner, MD, Associate Professor of Dermatology at the Mount Sinai Hospital in New York City, reviews the latest information on prescribing and monitoring isotretinoin for patients with severe nodulocystic acne and provides an update on the potential risks associated with this medication. Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 13, 2024

Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies. Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).

Dermatitis 36

Dermatitis Dermatology Clinic Skin Issues 36

The Dermatology Digest

MARCH 14, 2024

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, shares some congenital ichthyosis (CI) cases and discusses the importance of understanding patient and family expectations about CI treatment.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Chronic spontaneous urticaria (CSU) often has no identifiable trigger and is driven by mast cells, but symptoms are bothersome to patients, highlighting the need for effective treatments, says Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, shares three pearls on how to make these important differential diagnoses.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

First Derm

JUNE 5, 2023

Overview | Science behind Margarita Burns | How to identify Margarita dermatitis | Stages of symptoms | Treatment & prevention Welcome to the sizzling sensation of summer, where sun-kissed skies and refreshing drinks are the daily highlight. So, the treatment is mainly to relieve you from the pain and discomfort.

Dermatitis 40

Dermatitis Sun Protection Clinic Skin Sensitivity 40

The Dermatology Digest

MARCH 13, 2024

Watch Now Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo Emma Guttman-Yassky, MD, PhD Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes. Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 28

Dermatitis Dermatology Eczema Clinic 28

Aesthetics Advisor

MARCH 15, 2024

Department of Health proposed guidelines recommending the use of honey as a first line of treatment for coughs, as part of its goal to reduce inappropriate antibiotic use. The medical grade honeys have potent in vitro bactericidal activity against antibiotic-resistant bacteria causing several life-threatening infections to humans.”

Extractions 36

Extractions Medical Irritation Treatments 36

US Dermatologt Partners

APRIL 14, 2025

However, some rashes can be caused by infections, which may require more immediate attention and treatment. Bacterial skin rashes typically do not improve on their own; they are expected to worsen over time without proper treatment and may even develop into more serious conditions like necrotizing fasciitis, or sepsis.

Scarring 36

Scarring Skin Health Dermatitis Medical 36

West Lake Dermatology

APRIL 8, 2024

Issues such as peri-orificial dermatitis, rosacea, and folliculitis are commonly mistaken for acne and as such they are not treated effectively. In this blog post, we will examine some common acne-like conditions and shed light on their causes, symptoms, similarities to acne , and appropriate treatments.

Rosacea 36

Rosacea Dermatitis Exfoliation Irritation 36

The Beauty Brains

OCTOBER 17, 2016

According to Fisher’s Contact Dermatitis, acne can result from topical application of cosmetic products via two mechanisms. The results showed their products moisturize, reduce fine lines and wrinkles, etc, better than no treatment at all. That’s a great question but patch testing for acne does NOT work.

Sun Protection 40

Sun Protection Extractions Ingredients Comedogenic 40

First Derm

OCTOBER 1, 2023

Online Dermatologist Itchy Rash Pictures, Causes and Treatment Have you ever wondered what that red mark or spot is on your skin? Itchy Rash Treatment What Is A Rash? Atopic Dermatitis – Finger The cause of your rash could be due to a plethora of conditions. However, it doesn’t harm us to understand their cause.

Treatments 98

Treatments Eczema Dermatitis Dry Skin 98

The Dermatology Digest

JANUARY 29, 2024

Hilary Baldwin, MD, the Medical Director of the Acne Treatment & Research Center in Morristown, NJ, shares why she is so excited about Cabtreo (clindamycin phosphate 1.2%/adapalene Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Hospital in Detroit, explains how, when, and why she uses these new options.

Rosacea 36

Rosacea Dermatitis Hospital Dermatology 36

The Dermatology Digest

FEBRUARY 24, 2025

improved atopic dermatitis (AD) across all primary and secondary efficacy endpoints, with significant improvement as early as Week 1 on multiple efficacy endpoints in kids aged 2 to 5, according to the INTEGUMENT-PED Trial. Roflumilast cream 0.05% (Zoryve, Arcutis Biotherapeutics, Inc.) Roflumilast cream 0.3% is approved by the U.S.

Eczema 67

Eczema Dermatitis Safety Dermatology 67